Dr. Katz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2600 Kings Hwy
Shreveport, LA 71103Phone+1 318-212-4639Fax+1 318-212-8305
Education & Training
- MedStar Health/Georgetown University HospitalResidency, Radiation Oncology, 1996 - 2000
- Greater Baltimore Medical CenterInternship, Internal Medicine, 1995 - 1996
- University of Maryland School of MedicineClass of 1995
Certifications & Licensure
- LA State Medical License 1997 - 2025
- DC State Medical License 1997 - 2005
- VA State Medical License 1998 - 2002
- MD State Medical License 1996 - 2000
- American Board of Radiology Radiation Oncology
Clinical Trials
- RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE Start of enrollment: 2014 Jun 30
- Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer Start of enrollment: 2013 Aug 26
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 58 citationsPhase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer.Carryn M. Anderson, Christopher M. Lee, Deborah P. Saunders, Amarinthia Curtis, Neal Dunlap
Journal of Clinical Oncology. 2019-10-16 - 37 citationsDusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomize...Mahesh Kudrimoti, Amarintha Curtis, Samar Azawi, Francis P. Worden, Sanford Katz
Journal of Biotechnology. 2016-12-10 - 14 citationsDusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patientsMahesh Kudrimoti, Amarinthia Curtis, Samar Azawi, Francis P. Worden, Sanford Katz
Biotechnology Reports. 2017-09-01
Press Mentions
- Fourth Annual Proton Therapy Training Course to Be Held at Penn MedicineAugust 25th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: